Objectives: To analyze the utilization of intensive care unit (ICU) days in
a Canadian medical-surgical ICU and to identify ICU patients with prolonge
d ICU length of stay (LOS).
Design:Prospective descriptive study.
Setting. A Canadian tertiary care medical-surgical ICU.
Patients: Consecutive patients admitted to an adult medical-surgical ICU. N
eurosurgical, cardiac surgical, and coronary care unit patients were exclud
ed.
Measurements: For each ICU admission, patient demographics, diagnosis, Acut
e Physiology and Chronic Health Evaluation II (APACHE II) score, ICU LOS, a
nd hospital mortality were collected. The patients' risk of death was calcu
lated using the APACHE II equation. Admissions were stratified by ICU LOS i
nto four groups: 1 to 2, 3 to 6, 7 to 13, and greater than or equal to 14 d
ays. Among the four LOS groups, the number of ICU days and observed and pre
dicted death rates were compared. Admissions were also stratified by risk o
f death into five probability range quintiles. Among the five risk groups,
ICU LOS was compared between survivors and nonsurvivors.
Results: A total of 1,960 admissions utilized 9,298 ICU days. ICU LOS (mean
+/- SEM) was 4.74 +/- 0.2 (median, 2; range, 1 to 178) days. Short-stay pa
tients (ICU LOS less than or equal to 2 days) accounted for 60.3% of total
admissions but consumed only 16.4% of total ICU days. Long-stay patients (I
CU LOS greater than or equal to 14 days) accounted for 7.3% of total admiss
ions but consumed 43.5% of total ICU days. Among the long-stay patients, th
e most common reasons for admission were pneumonia, multiple trauma, neurom
uscular weakness, and septic shock. The mortality for long-stay patients ap
proached 50%. When analyzed by patients' mortality risks, those with a risk
of death >0.8 (predicted to die) or <0.2 (predicted to live) whose outcome
s were opposite to that predicted had twice the ICU LOS compared with patie
nts whose outcomes were consistent with prediction.
Conclusion: In a Canadian medical-surgical ICU, patients with ICU LOS great
er than or equal to 14 days accounted for 7.3% of total admissions but cons
umed 43.5% of total ICU days. Identification of patients with prolonged ICU
LOS who would ultimately die in the ICU may lead to earlier withdrawal of
therapy in these patients, resulting in a substantial reduction in sufferin
g and cost savings. In our study population, outcome prediction using the A
PACHE II equation did not provide sufficient power to accurately discrimina
te between nonsurvivors and survivors.